Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.12 | 26.60 |
| PEG Ratio (TTM) | 0.10 | -2.00 |
| P/S Ratio (TTM) | 0.08 | 2.04 |
| P/B Ratio (TTM) | 0.19 | 2.24 |
| P/FCF Ratio (TTM) | -0.23 | 15.04 |
| Price to 5YR AVG Earnings Ratio | N/A | 10.80 |
| Price to 5YR AVG FCF Ratio | N/A | 24.77 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -58.99% | 5.78% |
| ROE (TTM) | -112.26% | 11.22% |
| Net Profit Margin (TTM) | -68.20% | 7.06% |
| ROIC 5YR AVG | N/A | 9.85% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -18.61% | 721.03% | N/A |
| Revenue | -4.07% | 42.27% | N/A |
| Net Income | -18.29% | 326.12% | N/A |
| Cash Flow | 27.74% | -495.77% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.99 | 1.40 |
| Quick Ratio (TTM) | 0.31 | 0.81 |
| D/E Ratio (TTM) | 0.82 | 0.84 |
| Interest Coverage (TTM) | -106.44 | 10.90 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 3.28 |
| LTL to 5YR AVG FCF | N/A | 6.78 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.75% |